Form 4: Haoxi Health Technology Ltd: Director Fan Zhen Acquires Shares

Haoxi Health Technology Ltd reports a significant acquisition of Class B Ordinary Shares by Director Fan Zhen.

Summary

• Fan Zhen, a Director, 10% Owner, and CEO & Chairman of Haoxi Health Technology Ltd, acquired 40,000,000 Class B Ordinary Shares on May 19, 2026.
• The acquisition was made at a price of $0.018 per share.
• Following this transaction, Fan Zhen beneficially owns 40,690,800 Class B Ordinary Shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing due to a significant share purchase by a key insider, suggesting confidence in the company's value.

Positives

• Significant share acquisition by a key executive and director, indicating confidence in the company.
• The acquisition price of $0.018 per share suggests a potentially undervalued stock or a strategic accumulation of shares.

Future Outlook

No specific future outlook or guidance is provided in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider share acquisitions, particularly by high-ranking executives like CEOs and Chairmen, are often interpreted by the market as a positive signal of management's belief in the company's future prospects.

Stakeholder Impact

• Shareholders may view this acquisition positively, interpreting it as a sign of management's confidence in the company's future performance and potential undervaluation.

Key Dates

Recommendation

The acquisition by a key insider is a positive signal, but without further financial performance data or strategic updates in this specific filing, a 'hold' recommendation is prudent, suggesting investors monitor for further developments.

Keywords

Haoxi Health Technology Ltd, HAO, Form 4, Insider Trading, Share Acquisition, Director, CEO, Chairman, Beneficial Ownership, Class B Ordinary Shares